Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT07400575 2026-02-10

NSCLC SCLC

Not yet recruiting

350 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

41 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07320105 2026-01-06

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Phase 4 Recruiting

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07279402 2025-12-12

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

Recruiting

150 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05277844 2025-09-10

TARGET-01

Phase 2 Recruiting

106 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05278052 2025-09-10

TARGET-02

Phase 3 Recruiting

190 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07131163 2025-08-20

NoSurgery

Recruiting

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Phase 2 Recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

123 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03093688 2025-07-02

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

40 enrolled

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT07039994 2025-06-26

AIRPAL

Phase NA Recruiting

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06971406 2025-05-14

FLAME-1

Phase 2 Not yet recruiting

100 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06959173 2025-05-06

Organoid-guided Personalized Treatment of Pleural Effusion

Recruiting

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

NCT06939049 2025-04-22

SISTEMA

Recruiting

250 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06926803 2025-04-15

A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases

Active not recruiting

500 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06900283 2025-04-03

FACT-L_Pred

Active not recruiting

320 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

SARCO-CTI

NSCLC SCLC

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

TARGET-01

TARGET-02

NoSurgery

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

LEDANG

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

AIRPAL

FLAME-1

Organoid-guided Personalized Treatment of Pleural Effusion

SISTEMA

A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases

FACT-L_Pred